Deutsche Bank downgraded UnitedHealth from Buy to Hold and set a new price target of $333.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/29/2025 | $333.00 | Buy → Hold | Deutsche Bank |
| 10/14/2025 | $406.00 | Buy | Goldman |
| 7/31/2025 | $198.00 | Neutral → Underperform | Robert W. Baird |
| 7/30/2025 | $400.00 → $325.00 | Outperform | Oppenheimer |
| 6/11/2025 | $312.00 | Outperform → Neutral | Robert W. Baird |
| 5/21/2025 | $270.00 | Hold → Reduce | HSBC Securities |
| 5/19/2025 | $308.00 | Buy → Hold | TD Cowen |
| 5/14/2025 | Strong Buy → Mkt Perform | Raymond James |
10-Q - UNITEDHEALTH GROUP INC (0000731766) (Filer)
8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
8-K/A - UNITEDHEALTH GROUP INC (0000731766) (Filer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
Third Quarter 2025 Revenues of $113.2 Billion Grew 12% Year-Over-Year Third Quarter Earnings of $2.59 Per Share, Adjusted Earnings $2.92 Per Share Cash Flows from Operations were $5.9 Billion, or 2.3x Net Income Raises Full Year 2025 Earnings Outlook to at least $14.90 Per Share; Adjusted Earnings of at least $16.25 Per Share UnitedHealth Group (NYSE:UNH) reported third quarter 2025 results, reflecting the continued execution on its performance agenda, refocus on its mission and culture, and return to sustained growth. "We remain focused on strengthening performance and positioning for durable and accelerating growth in 2026 and beyond, and our results this quarter reflect so
UnitedHealthcare is committed to advancing Medicare Advantage by delivering better health outcomes, high-quality care and lower costs for taxpayers and beneficiaries when compared to Original Medicare Our 2026 offerings preserve access to affordable Medicare Advantage plans despite programmatic funding cuts UnitedHealthcare is modernizing coverage to address rising health care costs while protecting what matters most to Medicare consumers UnitedHealthcare® today introduced its 2026 Medicare Advantage plans, offering reliable coverage and benefits to meet the evolving needs of Medicare consumers. With more than 45 years of experience in serving Medicare beneficiaries and nearly two
HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), announced today that it has signed a national agreement with UnitedHealthcare Insurance Company (NYSE: UNH), effective September 15, 2025, covering over 51 million people throughout the United States, to provide the CNSide® Cerebrospinal Fluid Tumor Cell Enumeration laboratory developed test (LDT). The CNSide® CSF Assay Platform supports rapid diagnoses, treatment monitoring, and treatment guidance for patients with leptomeningeal metastases. The superior clinical utility of CNSide® over standard of care has been shown in 9 pee
Deutsche Bank downgraded UnitedHealth from Buy to Hold and set a new price target of $333.00
Goldman initiated coverage of UnitedHealth with a rating of Buy and set a new price target of $406.00
Robert W. Baird downgraded UnitedHealth from Neutral to Underperform and set a new price target of $198.00
Third Quarter 2025 Revenues of $113.2 Billion Grew 12% Year-Over-Year Third Quarter Earnings of $2.59 Per Share, Adjusted Earnings $2.92 Per Share Cash Flows from Operations were $5.9 Billion, or 2.3x Net Income Raises Full Year 2025 Earnings Outlook to at least $14.90 Per Share; Adjusted Earnings of at least $16.25 Per Share UnitedHealth Group (NYSE:UNH) reported third quarter 2025 results, reflecting the continued execution on its performance agenda, refocus on its mission and culture, and return to sustained growth. "We remain focused on strengthening performance and positioning for durable and accelerating growth in 2026 and beyond, and our results this quarter reflect so
AM Best has downgraded the Long-Term Issuer Credit Ratings (Long-Term ICR) to "a-" (Excellent) from "a" (Excellent) and the Long and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). Concurrently AM Best has downgraded the Financial Strength Rating (FSR) to A (Excellent) from A+ (Superior) and the Long-Term ICRs to "a+" (Excellent) from "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) has been revised to stable from negative. (See link below for a detailed listing of
The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on September 23, 2025, to all shareholders of record of UNH common stock as of the close of business September 15, 2025. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range o
NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr
UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)